A genetic screen identifies Tor as an interactor of VAPB in a Drosophila model of amyotrophic lateral sclerosis

Biology Open

Volumn 3, Issue 11, 2014, Pages 1127-1138

  Deivasigamani, Senthilkumar ^a   Verma, Hemant Kumar ^a   Ueda, Ryu ^b   Ratnaparkhi, Anuradha ^a,c   Ratnaparkhi, Girish S ^a  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

^b NATIONAL INSTITUTE OF GENETICS   (Japan)

^c AGHARKAR RESEARCH INSTITUTE   (India)

Author keywords

ALS; Drosophila rnai screen; Neurodegeneration; TOR; VAP

Indexed keywords

EID: 84979943896     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.201410066     Document Type: Article

References (75)

1. Aliaga, L., Lai, C., Yu, J., Chub, N., Shim, H., Sun, L., Xie, C., Yang, W. J., Lin, X., O'Donovan, M. J. et al. (2013). Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons. Hum. Mol. Genet. 22, 4293-4305.
2. Amarilio, R., Ramachandran, S., Sabanay, H. and Lev, S. (2005). Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. J. Biol. Chem. 280, 5934-5944.
3. Ambegaokar, S. S. and Jackson, G. R. (2011). Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation. Hum. Mol. Genet. 20, 4947-4977.
4. Andersen, P. M. and Al-Chalabi, A. (2011). Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 7, 603-615.
5. Caccamo, A., Majumder, S., Deng, J. J., Bai, Y., Thornton, F. B. and Oddo, S. (2009). Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J. Biol. Chem. 284, 27416-27424.
6. Caccamo, A., Majumder, S., Richardson, A., Strong, R. and Oddo, S. (2010). Molecular interplay between mammalian target of rapamycin (mTOR), amyloidbeta, and Tau: effects on cognitive impairments. J. Biol. Chem. 285, 13107-13120.
7. Chen, X. and Burgoyne, R. D. (2012). Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms. BMC Genomics 13, 71.
8. Chen, H. J., Anagnostou, G., Chai, A., Withers, J., Morris, A., Adhikaree, J., Pennetta, G. and de Belleroche, J. S. (2010). Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J. Biol. Chem. 285, 40266-40281.
9. Cheng, L., Locke, C. and Davis, G. W. (2011). S6 kinase localizes to the presynaptic active zone and functions with PDK1 to control synapse development. J. Cell Biol. 194, 921-935.
10. Ching, J. K., Elizabeth, S. V., Ju, J. S., Lusk, C., Pittman, S. K. and Weihl, C. C. (2013). mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy. Hum. Mol. Genet. 22, 1167-1179.
11. Christianson, J. C., Olzmann, J. A., Shaler, T. A., Sowa, M. E., Bennett, E. J., Richter, C. M., Tyler, R. E., Greenblatt, E. J., Harper, J. W. and Kopito, R. R. (2012). Defining human ERAD networks through an integrative mapping strategy. Nat. Cell Biol. 14, 93-105.
12. Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L., Toufighi, K., Mostafavi, S. et al. (2010). The genetic landscape of a cell. Science 327, 425-431.
13. De Vos, K. J., Mórotz, G. M., Stoica, R., Tudor, E. L., Lau, K. F., Ackerley, S., Warley, A., Shaw, C. E. and Miller, C. C. (2012). VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum. Mol. Genet. 21, 1299-1311.
14. Dormann, D., Rodde, R., Edbauer, D., Bentmann, E., Fischer, I., Hruscha, A., Than, M. E., Mackenzie, I. R., Capell, A., Schmid, B. et al. (2010). ALSassociated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 29, 2841-2857.
15. Floto, R. A., Sarkar, S., Perlstein, E. O., Kampmann, B., Schreiber, S. L. and Rubinsztein, D. C. (2007). Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages. Autophagy 3, 620-622.
16. Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C. et al. (2013). STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808-D815.
17. Gkogkas, C., Middleton, S., Kremer, A. M., Wardrope, C., Hannah, M., Gillingwater, T. H. and Skehel, P. (2008). VAPB interacts with and modulates the activity of ATF6. Hum. Mol. Genet. 17, 1517-1526.
18. Guruharsha, K. G., Rual, J. F., Zhai, B., Mintseris, J., Vaidya, P., Vaidya, N., Beekman, C., Wong, C., Rhee, D. Y., Cenaj, O. et al. (2011). A protein complex network of Drosophila melanogaster. Cell 147, 690-703.
19. Han, S. M., Tsuda, H., Yang, Y., Vibbert, J., Cottee, P., Lee, S. J., Winek, J., Haueter, C., Bellen, H. J. and Miller, M. A. (2012). Secreted VAPB/ALS8 major sperm protein domains modulate mitochondrial localization and morphology via growth cone guidance receptors. Dev. Cell 22, 348-362.
20. Han, J., Back, S. H., Hur, J., Lin, Y. H., Gildersleeve, R., Shan, J., Yuan, C. L., Krokowski, D., Wang, S., Hatzoglou, M. et al. (2013a). ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat. Cell Biol. 15, 481-490.
21. Han, J. H., Yu, T. H., Ryu, H. H., Jun, M. H., Ban, B. K., Jang, D. J. and Lee, J. A. (2013b). ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons. Exp. Cell Res. 319, 1998-2005.
22. Harris, T. E. and Lawrence, J. C., Jr. (2003). TOR signaling. Sci. STKE 2003,re15.
23. Hartai, Z., Klivenyi, P., Janaky, T., Penke, B., Dux, L. and Vecsei, L. (2005). Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease. J. Neurol. Sci. 239, 31-35.
24. Heitman, J., Movva, N. R. and Hall, M. N. (1991). Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905-909.
25. Hoeffer, C. A. and Klann, E. (2010). mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67-75.
26. Hu, Y., Flockhart, I., Vinayagam, A., Bergwitz, C., Berger, B., Perrimon, N. and Mohr, S. E. (2011). An integrative approach to ortholog prediction for diseasefocused and other functional studies. BMC Bioinformatics 12, 357.
27. Huang, D. W., Sherman, B. T. and Lempicki, R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57.
28. Johnson, S. C., Rabinovitch, P. S. and Kaeberlein, M. (2013). mTOR is a key modulator of ageing and age-related disease. Nature 493, 338-345.
29. Kabashi, E., El Oussini, H., Bercier, V., Gros-Louis, F., Valdmanis, P. N., McDearmid, J., Mejier, I. A., Dion, P. A., Dupre, N., Hollinger, D. et al. (2013). Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 2350-2360.
30. Kaltenbach, L. S., Romero, E., Becklin, R. R., Chettier, R., Bell, R., Phansalkar, A., Strand, A., Torcassi, C., Savage, J., Hurlburt, A. et al. (2007). Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet. 3, e82.
31. Kambris, Z., Brun, S., Jang, I. H., Nam, H. J., Romeo, Y., Takahashi, K., Lee, W. J., Ueda, R. and Lemaitre, B. (2006). Drosophila immunity: a large-scale in vivo RNAi screen identifies five serine proteases required for Toll activation. Curr. Biol. 16, 808-813.
32. Laplante, M. and Sabatini, D. M. (2012). mTOR signaling in growth control and disease. Cell 149, 274-293.
33. Lev, S., Ben Halevy, D., Peretti, D. and Dahan, N. (2008). The VAP protein family: from cellular functions to motor neuron disease. Trends Cell Biol. 18, 282-290.
34. Lin, A., Wang, R. T., Ahn, S., Park, C. C. and Smith, D. J. (2010). A genomewide map of human genetic interactions inferred from radiation hybrid genotypes. Genome Res. 20, 1122-1132.
35. Liu, S. and Lu, B. (2010). Reduction of protein translation and activation of autophagy protect against PINK1 pathogenesis in Drosophila melanogaster. PLoS Genet. 6, e1001237.
36. Malagelada, C., Jin, Z. H., Jackson-Lewis, V., Przedborski, S. and Greene, L. A. (2010). Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. J. Neurosci. 30, 1166-1175.
37. Marygold, S. J., Leyland, P. C., Seal, R. L., Goodman, J. L., Thurmond, J., Strelets, V. B. and Wilson, R. J.; FLYBASE CONSORTIUM. (2013). FlyBase: improvements to the bibliography. Nucleic Acids Res. 41, D751-D757.
38. Mitne-Neto, M., Ramos, C. R., Pimenta, D. C., Luz, J. S., Nishimura, A. L., Gonzales, F. A., Oliveira, C. C. and Zatz, M. (2007). A mutation in human VAP-B-MSP domain, present in ALS patients, affects the interaction with other cellular proteins. Protein Expr. Purif. 55, 139-146.
39. Mórotz, G. M., De Vos, K. J., Vagnoni, A., Ackerley, S., Shaw, C. E. and Miller, C. C. (2012). Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum. Mol. Genet. 21, 1979-1988.
40. Mostafavi, S., Ray, D., Warde-Farley, D., Grouios, C. and Morris, Q. (2008). GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biol. 9 Suppl. 1, S4.
41. Moustaqim-Barrette, A., Lin, Y. Q., Pradhan, S., Neely, G. G., Bellen, H. J. and Tsuda, H. (2014). The amyotrophic lateral sclerosis 8 protein, VAP, is required for ER protein quality control. Hum. Mol. Genet. 23, 1975-1989.
42. Natarajan, R., Trivedi-Vyas, D. and Wairkar, Y. P. (2013). Tuberous sclerosis complex regulates Drosophila neuromuscular junction growth via the TORC2/ Akt pathway. Hum. Mol. Genet. 22, 2010-2023.
43. Nikawa, J., Murakami, A., Esumi, E. and Hosaka, K. (1995). Cloning and sequence of the SCS2 gene, which can suppress the defect of INO1 expression in an inositol auxotrophic mutant of Saccharomyces cerevisiae. J. Biochem. 118, 39-45.
44. Nishimura, Y., Hayashi, M., Inada, H. and Tanaka, T. (1999). Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins. Biochem. Biophys. Res. Commun. 254, 21-26.
45. Nishimura, A. L., Mitne-Neto, M., Silva, H. C., Richieri-Costa, A., Middleton, S., Cascio, D., Kok, F., Oliveira, J. R., Gillingwater, T., Webb, J. et al. (2004). A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75, 822-831.
46. Nishimura, A. L., Al-Chalabi, A. and Zatz, M. (2005). A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population. Hum. Genet. 118, 499-500.
47. Pasinelli, P. and Brown, R. H. (2006). Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710-723.
48. Pennetta, G., Hiesinger, P. R., Fabian-Fine, R., Meinertzhagen, I. A. and Bellen, H. J. (2002). Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner. Neuron 35, 291-306.
49. Penney, J., Tsurudome, K., Liao, E. H., Elazzouzi, F., Livingstone, M., Gonzalez, M., Sonenberg, N. and Haghighi, A. P. (2012). TOR is required for the retrograde regulation of synaptic homeostasis at the Drosophila neuromuscular junction. Neuron 74, 166-178.
50. Pennuto, M., Tinelli, E., Malaguti, M., Del Carro, U., D'Antonio, M., Ron, D., Quattrini, A., Feltri, M. L. and Wrabetz, L. (2008). Ablation of the UPRmediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron 57, 393-405.
51. Peretti, D., Dahan, N., Shimoni, E., Hirschberg, K. and Lev, S. (2008). Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport. Mol. Biol. Cell 19, 3871-3884.
52. Perry, R. J. and Ridgway, N. D. (2006). Oxysterol-binding protein and vesicleassociated membrane protein-associated protein are required for steroldependent activation of the ceramide transport protein. Mol. Biol. Cell 17, 2604-2616.
53. Prause, J., Goswami, A., Katona, I., Roos, A., Schnizler, M., Bushuven, E., Dreier, A., Buchkremer, S., Johann, S., Beyer, C. et al. (2013). Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 1581-1600.
54. Rao, M., Song, W., Jiang, A., Shyr, Y., Lev, S., Greenstein, D., Brantley-Sieders, D. and Chen, J. (2012). VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity. PLoS ONE 7, e46281.
55. Ratnaparkhi, A., Lawless, G. M., Schweizer, F. E., Golshani, P. and Jackson, G. R. (2008). A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism. PLoS ONE 3, e2334.
56. Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J. et al. (2004). Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585-595.
57. Sen, A., Dimlich, D. N., Guruharsha, K. G., Kankel, M. W., Hori, K., Yokokura, T., Brachat, S., Richardson, D., Loureiro, J., Sivasankaran, R. et al. (2013). Genetic circuitry of Survival motor neuron, the gene underlying spinal muscular atrophy. Proc. Natl. Acad. Sci. USA 110, E2371-E2380.
58. Shulman, J. M. and De Jager, P. L. (2009). Evidence for a common pathway linking neurodegenerative diseases. Nat. Genet. 41, 1261-1262.
59. Silva, M. C., Fox, S., Beam, M., Thakkar, H., Amaral, M. D. and Morimoto, R. I. (2011). A genetic screening strategy identifies novel regulators of the proteostasis network. PLoS Genet. 7, e1002438.
60. Skehel, P. A., Martin, K. C., Kandel, E. R. and Bartsch, D. (1995). A VAMPbinding protein from Aplysia required for neurotransmitter release. Science 269, 1580-1583.
61. Skehel, P. A., Fabian-Fine, R. and Kandel, E. R. (2000). Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. Proc. Natl. Acad. Sci. USA 97, 1101-1106.
62. Spilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R. and Galvan, V. (2010). Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS ONE 5, e9979.
63. Teuling, E., Ahmed, S., Haasdijk, E., Demmers, J., Steinmetz, M. O., Akhmanova, A., Jaarsma, D. and Hoogenraad, C. C. (2007). Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J. Neurosci. 27, 9801-9815.
64. Thorp, E., Li, G., Seimon, T. A., Kuriakose, G., Ron, D. and Tabas, I. (2009). Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe2/2 and Ldlr2/2 mice lacking CHOP. Cell Metab. 9, 474-481.
65. Tran, D., Chalhoub, A. and Schooley, A., Zhang, W. and Ngsee, J. K. (2012). A mutation in VAPB that causes amyotrophic lateral sclerosis also causes a nuclear envelope defect. J. Cell Sci. 125, 2831-2836.
66. Tsuda, H., Han, S. M., Yang, Y., Tong, C., Lin, Y. Q., Mohan, K., Haueter, C., Zoghbi, A., Harati, Y., Kwan, J. et al. (2008). The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell 133, 963-977.
67. Tudor, E. L., Galtrey, C. M., Perkinton, M. S., Lau, K. F., De Vos, K. J., Mitchell, J. C., Ackerley, S., Hortobágyi, T., Vámos, E., Leigh, P. N. et al. (2010). Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience 167, 774-785.
68. van Blitterswijk, M., Vlam, L., van Es, M. A., van der Pol, W. L., Hennekam, E. A., Dooijes, D., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., Veldink, J. H. et al. (2012). Genetic overlap between apparently sporadic motor neuron diseases. PLoS ONE 7, e48983.
69. van Ham, T. J., Thijssen, K. I., Breitling, R., Hofstra, R. M., Plasterk, R. H., Nollen, E. A. (2008). C. elegans model identifies genetic modifiers of alphasynuclein inclusion formation during aging. PLoS Genet. 4, e1000027.
70. Wang, T., Lao, U. and Edgar, B. A. (2009). TOR-mediated autophagy regulates cell death in Drosophila neurodegenerative disease. J. Cell Biol. 186, 703-711.
71. Wijesekera, L. C. and Leigh, P. N. (2009). Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 4, 3.
72. Yang, Z., Huh, S. U., Drennan, J. M., Kathuria, H., Martinez, J. S., Tsuda, H., Hall, M. C. and Clemens, J. C. (2012). Drosophila Vap-33 is required for axonal localization of Dscam isoforms. J. Neurosci. 32, 17241-17250.
73. Zhang, S., Binari, R., Zhou, R. and Perrimon, N. (2010). A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 184, 1165-1179.
74. Zhang, X., Li, L., Chen, S., Yang, D., Wang, Y., Zhang, X., Wang, Z. and Le, W. (2011). Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy 7, 412-425.
75. Zoncu, R., Efeyan, A. and Sabatini, D. M. (2011). mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35.